Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Journal of Environmental Pathology, Toxicology and Oncology
Импакт фактор: 1.241 5-летний Импакт фактор: 1.349 SJR: 0.356 SNIP: 0.613 CiteScore™: 1.61

ISSN Печать: 0731-8898
ISSN Онлайн: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.v30.i4.70
pages 341-354

MET and Phosphorylated MET as Potential Biomarkers in Lung Cancer

Maria Tretiakova
University of Chicago, Department of Pathology, Chicago, Illinois
April K.S. Salama
University of Chicago, Department of Medicine, Section of Hematology/Oncology, and University of Chicago Cancer Research Center, Chicago, Illinois
Theodore Karrison
University of Chicago, Department of Health Studies, Chicago, Illinois; and "University of Chicago, Department of Surgery, Section of Cardiac and Thoracic Surgery, and University of Chicago Cancer Research Center, Chicago, Illinois
Mark K. Ferguson
Department of Surgery; University of Chicago, Chicago, IL
Aliya N. Husain
University of Chicago, Department of Pathology, Chicago, Illinois
Everett E. Vokes
University of Chicago, Department of Medicine, Section of Hematology/Oncology, and University of Chicago Cancer Research Center, Chicago, Illinois
Ravi Salgia
Department of Medical Oncology and Therapeutics Research, Comprehensive Cancer Center, City of Hope National Medical Center

Краткое описание

This study aimed to investigate the expression and prognostic role of the receptor tyrosine kinase MET, phosphorylated MET, and the ligand hepatocyte growth factor (HGF) in patients with lung cancer. This retrospective study included 129 patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) with available tumor tissue and survival data. MET, pMET, and HGF expression were assessed using immunohistochemistry. MET, pMET, and HGF were more highly expressed in tumor tissue when compared to the adjacent lung parenchyma. A specific localization pattern was also evident: membranous, cytoplasmic, and nuclear patterns of expression were seen for MET, pMET, and HGF. In addition, high expression of two specific forms of phosphorylated MET−cytoplasmic expression of Y1003 and nuclear expression of Y1365−appeared to correlate with a worse overall survival (P = .016; hazard ratio [HR], 1.86; 95% confidence interval [95% CI], 1.12— 3.07; and P = .034; HR, 1.70; 95% CI, 1.04—2.78, respectively). In summary, MET, pMET, and HGF are highly expressed in both NSCLC and SCLC. Specific forms of pMET may serve as potential biomarkers in lung cancer.


Articles with similar content:

Tumor Suppressor Maspin as a Rheostat in HDAC Regulation to Achieve the Fine-Tuning of Epithelial Homeostasis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.22, 2012, issue 3
M. Margarida Bernardo, Shijie Sheng, Sijana Dzinic, Alexander Kaplun
Cell Cycle Regulators Modulating Con A Mitogenesis and Apoptosis in Low-Dose Radiation-Exposed Mice
Journal of Environmental Pathology, Toxicology and Oncology, Vol.24, 2005, issue 1
Krishna B. Sainis, Bhavani Shankar
Dietary Turmeric Post-Treatment Decreases DMBA-Induced Hamster Buccal Pouch Tumor Growth by Altering Cell Proliferation and Apoptosis-Related Markers
Journal of Environmental Pathology, Toxicology and Oncology, Vol.31, 2012, issue 4
Pooja Tajpara, Gaurav Kumar, Girish Maru
Surgical Resection of Retroperitoneal Sarcomas: Analysis of Factors Determining Outcome
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 1-2
Allan W. Silberman , Charles Forscher, Farin Amersi
Protective Effect of Solanum muricatum on Tumor Metastasis by Regulating Inflammatory Mediators and Nuclear Factor-Kappa B Subunits
Journal of Environmental Pathology, Toxicology and Oncology, Vol.34, 2015, issue 3
Chandrasekaran Guruvayoorappan, Kittappa Shathish, Kunnathur Murugesan Sakthivel